- SPACs
- Black Hawk Acquisition Corp
Black Hawk Acquisition Corp
Definitive agreement 2025-04-26- CIK 2000775
- BKHA
- IPO 2024-03-22
- $26M trust
- 119 filings
- IPO Size
- $69M
- raised at the IPO
- Trust
- $26M
- as of 2026-08-31
- Current Status
- Proxy Vote
- from its latest filing
- IPO Year
- 2024
- year it listed
Filings, by quarter
119 filings over 13 quarters; violet bars carry a milestone
- 23 Q4: 1 filing
- 24 Q1: 22 filings
- 24 Q2: 9 filings
- 24 Q3: 1 filing
- 24 Q4: 6 filings
- 25 Q1: 4 filings
- 25 Q2: 19 filings
- 25 Q3: 14 filings
- 25 Q4: 9 filings
- 26 Q1: 8 filings
- 26 Q2: 7 filings
- 26 Q3: 12 filings
- 26 Q4: 7 filings
- S-1 filed 23 Q4
- IPO 24 Q1
- Definitive agreement 25 Q2
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2023-12-21 Filed S1
- IPO2024-03-22 IPO, search begins
- Definitive Agreement2025-04-26 Agreement for merger
- CompletedNot yet completed
About
Black Hawk Acquisition Corp. is a newly formed blank-check company seeking to effect an initial business combination with one or more businesses. Its search is not limited to a particular industry or geographic region.
Key Information
As the filings state it
- IPO Date
- 2024-03-22
- Total Redemptions
- $76.2M
- PIPE
- $10M
- SIC
- 6770
- Merger Target
- Vesicor Therapeutics, Inc.
- SPAC Ticker
- BKHA
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Kent Louis Kaufman has more than 30 years in executive roles, management consulting and executive coaching, including leadership experience at StorMedia and IBM. The independent director nominees bring backgrounds in property management and consulting, law, and retail and business management.